{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:43:18Z","timestamp":1788964998558,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neurobiolaging.2016.12.017","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T20:30:50Z","timestamp":1482870650000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["A review of human diseases caused or exacerbated by aberrant complement activation"],"prefix":"10.1016","volume":"52","author":[{"given":"Patrick L.","family":"McGeer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith G.","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib1","doi-asserted-by":"crossref","first-page":"e0122048","DOI":"10.1371\/journal.pone.0122048","article-title":"Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis","volume":"10","author":"Aeinehband","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM199005103221903","article-title":"Enhanced local production of complement components in the small intestines of patients with Crohn's disease","volume":"322","author":"Ahrenstedt","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis revisited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog. Ret. Eye Res."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0404.2008.01002.x","article-title":"Neuromyelitis optica: a distinct demyelinating disease of the central nervous system","volume":"118","author":"Argyriou","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2007.01.015","article-title":"Complement activation in experimental and human temporal lobe epilepsy","volume":"26","author":"Aronica","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El Idrissi","year":"2016","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-1759(84)90470-8","article-title":"Quantitation of complement Factor D in human serum by a solid-phase radioimmunoassay","volume":"67","author":"Barnum","year":"1984","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/08977150152725605","article-title":"Complement activation in human brain after traumatic brain injury","volume":"18","author":"Bellander","year":"2001","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.molmed.2014.01.001","article-title":"Complement activation in malaria: friend or foe?","volume":"20","author":"Biryukov","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1742-2094-9-137","article-title":"Complement activation in the injured central nervous system: another dual-edged sword?","volume":"9","author":"Brennan","year":"2012","journal-title":"J.\u00a0Neuroinflamation"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical genotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib14","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.1780341209","article-title":"Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis","volume":"34","author":"Brodeur","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2990.1989.tb01231.x","article-title":"Immunocytochemical localization of the terminal complement complex in multiple sclerosis","volume":"15","author":"Compston","year":"1989","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archderm.1985.01660010074022","article-title":"Membrane attack complex of complement in dermatitis herpetiformis","volume":"121","author":"Dahl","year":"1985","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00430-014-0347-0","article-title":"Malaria anemia: digestive vacuole of Plasmodium falciparum mediates complement deposition in bystander cells to provoke hemophagocytosis","volume":"203","author":"Dasari","year":"2014","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2119\/molmed.2010.00149","article-title":"New insights of an old defense system: structure, function, and clinical relevance of the complement system","volume":"17","author":"Ehrnthaller","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02890024","volume":"56","author":"Eikelenboom","year":"1989","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00685397","article-title":"Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study","volume":"57","author":"Eikelenboom","year":"1982","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02890185","article-title":"An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer's dementia","volume":"47","author":"Eikelenboom","year":"1984","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.molimm.2012.12.006","article-title":"Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome","volume":"54","author":"Fan","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib24","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.4049\/jimmunol.1103812","article-title":"Malaria inhibits surface expression of complement receptor 1 in monocytes\/macrophages, causing decreased immune complex internalization","volume":"190","author":"Fernandez-Arias","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib25","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.1195821","article-title":"Structures of C3b in complex with Factors B and D give insight into complement convertase formation","volume":"330","author":"Formeris","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib26","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1182\/blood-2011-06-359646","article-title":"Design and development of TT30, a novel C3d-targeted C3\/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases","volume":"118","author":"Fridkis-Harell","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib27","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.156.6.2247","article-title":"Identification and characterization of complement C3 receptors on human astrocytes","volume":"156","author":"Gasque","year":"1996","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF02919746","article-title":"Local complement activation in inflammatory bowel disease","volume":"10","author":"Halstensen","year":"1991","journal-title":"Immunol. Res."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI103296","article-title":"The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria","volume":"35","author":"Hinz","year":"1956","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","article-title":"Complement and its receptors: new insights into human disease","volume":"32","author":"Holers","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib35","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molimm.2012.10.033","article-title":"Elevated C1rC1sC1inh levels independently predict atherosclerotic coronary heart disease","volume":"54","author":"Horv\u00e1th","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MNH.0b013e3282f0872f","article-title":"Update on evaluating complement in hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2007","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib38","first-page":"691","article-title":"Immunological reactions in amyotrophic lateral sclerosis brain and spinal cord tissue","volume":"140","author":"Kawamata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/1523-1747.ep12709624","article-title":"Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin","volume":"92","author":"Kawana","year":"1989","journal-title":"J.\u00a0Inves. Dermatol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib40","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","article-title":"Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","article-title":"Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica","volume":"254","author":"Kuroda","year":"2013","journal-title":"J.\u00a0Neuroimmunol"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.neurobiolaging.2012.10.023","article-title":"Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages","volume":"34","author":"Lee","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib45","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.neurobiolaging.2011.12.005","article-title":"Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib47","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3892\/or.2014.3489","article-title":"C5a stimulates the proliferation of breast cancer cells via the Akt-dependent RGC-32 gene activation","volume":"32","author":"Lu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2014.06.055","article-title":"Meta-analysis of the association between CR 1 polymorphisms and risk of late-onset Alzheimer's disease","volume":"578","author":"Luo","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.gde.2006.04.015","article-title":"Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism","volume":"16","author":"Luzzatto","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib50","doi-asserted-by":"crossref","first-page":"1766.e5","DOI":"10.1016\/j.neurobiolaging.2015.01.006","article-title":"Alzheimer's disease is associated with low density of the long CR 1 isoform","volume":"36","author":"Mahmoudi","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/eji.1830080702","article-title":"Activation of the alternative complement pathway by human B-cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells","volume":"8","author":"McConnell","year":"1978","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib53","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S0317167100029863","article-title":"Immune system response in Alzheimer's disease","volume":"16","author":"McGeer","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","article-title":"Activation of the classical complement pathway in brain tissue of Alzheimer patients","volume":"107","author":"McGeer","year":"1989","journal-title":"Neurosci. Lett."},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2016.12.017_bib120","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0140-6736(90)91101-F","article-title":"Does anti-inflammatory treatment protect against Alzheimer disease?","volume":"335","author":"McGeer","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and antiinflammatory agents as negative risk factors for Alzheimer disease: a review of seventeen epidemiological studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ana.24398","article-title":"Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus","volume":"77","author":"Michailidou","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(84)90298-8","article-title":"Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis","volume":"2","author":"Morgan","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib60","first-page":"473","article-title":"Measurement of terminal complement complexes in rheumatoid arthritis","volume":"73","author":"Morgan","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria using modern diagnostic assays Brit","volume":"166","author":"Moyo","year":"2004","journal-title":"J.\u00a0Haematol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.58.3.175","article-title":"Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patient: immunohistochemical studies with an active form specific antibody","volume":"58","author":"Nakagawa","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib121","first-page":"1039","article-title":"Persistent complement activation on tumor cells in breast cancer","volume":"140","author":"Niculescu","year":"1992","journal-title":"Am J Pathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib63","first-page":"147","article-title":"Activation of the human terminal complement pathway in atherosclerosis","volume":"45","author":"Niculescu","year":"1987","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib64","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/or.2014.3341","article-title":"Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness","volume":"32","author":"Nitta","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib65","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1158\/1078-0432.CCR-12-1204","article-title":"Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88)","volume":"19","author":"Nitta","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.07.001","article-title":"Complement activation in patients with neuromyelitis optica","volume":"274","author":"Nytrova","year":"2014","journal-title":"J.\u00a0Neuroimmunol"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib67","first-page":"1","article-title":"Rheumatoid arthritis and the complement system","volume":"1","author":"Okroj","year":"2007","journal-title":"Ann. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2006.12.016","article-title":"Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques","volume":"195","author":"Oksjoki","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/03009749109103019","article-title":"C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis","volume":"20","author":"Olmez","year":"1991","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib70","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MEG.0000000000000042","article-title":"Faecal analysis and plasma complement factor C3 levels at admission for an acute attack of ulcerative colitis are predictive for the need for colectomy","volume":"26","author":"Pagoldh","year":"2014","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib71","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1084\/jem.20072248","article-title":"C5 deficiency and C5a or C5aR blockade protects against cerebral malaria","volume":"205","author":"Patel","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib72","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.1780200202","article-title":"Correlation between levels of breakdown products of C3, C4 and properdin factor B in synovial fluids from patients with rheumatoid arthritis","volume":"20","author":"Perrin","year":"1977","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2013.04.001","article-title":"Complement inhibition in cancer therapy","volume":"25","author":"Pio","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib74","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib75","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/gut.20.11.1012","article-title":"C1q in ulcerative colitis and Crohn's disease","volume":"20","author":"Potter","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/clin.1996.0071","article-title":"Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic","volume":"79","author":"Radillo","year":"1996","journal-title":"Clin. Immunol. Immunopathol"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4614-4118-2_10","article-title":"Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and anticomplement strategies","volume":"735","author":"Risitano","year":"2013","journal-title":"Adv. Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib78","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1182\/blood-2011-12-398792","article-title":"The complement receptor 2\/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment opsonization","volume":"119","author":"Risitano","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/335079a0","article-title":"A\u00a0highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite","volume":"335","author":"Robson","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib80","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by b-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2230.1990.tb02011.x","article-title":"Complement activation in psoriasis","volume":"15","author":"Rosenberg","year":"1990","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib82","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.2337\/dc13-0203","article-title":"Increased complement activation in human type 1 diabetes pancreatica","volume":"36","author":"Rowe","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib83","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/art.1780180401","article-title":"Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis","volume":"18","author":"Ruddy","year":"1975","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib84","first-page":"305","article-title":"Levels of SC5b-9 complement complex in plasma and synovial fluid of patients with rheumatoid arthritis","volume":"28","author":"Rus","year":"1990","journal-title":"Med. Intern."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib85","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/1541-7786.MCR-10-0225","article-title":"Cancer and the complement cascade","volume":"11","author":"Rutkowski","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib86","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.4049\/jimmunol.136.12.4456","article-title":"Activated terminal complement in cerebrospinal fluid in Guillain-Barre syndrome and multiple sclerosis","volume":"136","author":"Sanders","year":"1986","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib87","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jocn.2014.03.015","article-title":"CR1 is potentially associated with rate of decline in sporadic Alzheimer's disease","volume":"21","author":"Schmidt","year":"2014","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/exnr.2001.7851","article-title":"Complement activated C4d immunoreactive oligodendrocytes delineate early plaques in multiple sclerosis","volume":"174","author":"Schwab","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(73)93006-7","article-title":"Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis","volume":"7822","author":"Seah","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib90","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib91","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1462-5822.2010.01492.x","article-title":"Complement driven innate immune response to malaria: fuelling severe malarial diseases","volume":"12","author":"Silver","year":"2010","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib92","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/eurheartj\/ehi339","article-title":"Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis","volume":"26","author":"Speidl","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib93","first-page":"211","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation Neurobiol","volume":"42","author":"Sta","year":"2011","journal-title":"Aging"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib94","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/089771501316919139","article-title":"Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury","volume":"18","author":"Stahel","year":"2001","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib95","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0090-1229(85)90067-4","article-title":"Complement activation in type 1 human diabetes","volume":"35","author":"Sundsmo","year":"1985","journal-title":"Clin. Immunol. Immunopathol"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib96","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","article-title":"Deficiency of the GPI anchor caused by a somatic mutation in the PIG-A gene in paroxysmal nocturnal hemoglobinuria","volume":"73","author":"Takeda","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib97","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000247461","article-title":"Generation of terminal complement complexes in psoriatic lesioned skin","volume":"185","author":"Takematsu","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib98","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0006-8993(97)00849-4","article-title":"Neurons express proteins of the classical complement pathway in Alzheimer disease","volume":"769","author":"Terai","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib99","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2013.01.019","article-title":"Association of complement factor H tyrosine 402 histidine genotype with posterior involvement in sarcoid-related uveitis","volume":"155","author":"Thompson","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.ATV.18.9.1386","article-title":"C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib101","first-page":"225","article-title":"Impaired expression of erythrocyte glycol-phosphotidylinosotol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation","volume":"21","author":"Triolo","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jocn.2012.12.022","article-title":"Neuromyelitis optica: concept. Immunology and treatment","volume":"21","author":"Uzawa","year":"2014","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib104","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/BCR.0b013e318198a252","article-title":"Acute inflammation is persistent in burn wounds: a pivotal role for complement and C-reactive protein","volume":"30","author":"Van de Goot","year":"2009","journal-title":"J.\u00a0Burn Care Res."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bjo.70.1.60","article-title":"Complement activation in uveitis","volume":"70","author":"Vergani","year":"1986","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib106","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2013.09.010","article-title":"A\u00a0systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission","volume":"57","author":"Veszeli","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib107","first-page":"70044","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"13","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(85)90030-9","article-title":"Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque","volume":"57","author":"Vlaicu","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0169-328X(92)90017-6","article-title":"Complement gene expression in human brains: comparison between normal and Alzheimer disease cases","volume":"14","author":"Walker","year":"1992","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0305-4179(98)00013-8","article-title":"A\u00a0longitudinal study of C3, C3d, and factor Ba in burn patients in Hong Kong Chinese","volume":"24","author":"Wan","year":"1998","journal-title":"Burns"},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/sji.12132","article-title":"Increased soluble C5b-9 in CSF of neuromyelitis optica","volume":"79","author":"Wang","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib113","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/bjophthalmol-2014-305296","article-title":"CFl-rs 7356506 is a genetic protective factor for acute anterior uveitis in Chinese patients","volume":"98","author":"Wang","year":"2014","journal-title":"B.\u00a0J. Ophthalmol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib114","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0074-7742(07)79029-3","article-title":"Neuromyelitis optica: new findings on pathogenesis","volume":"79","author":"Wingerchuk","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.21729","article-title":"Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products","volume":"54","author":"Wouters","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib116","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib117","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","article-title":"Upregulated production and activation of the complement system in Alzheimer disease brain","volume":"154","author":"Yasojima","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib118","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/hq0701.092160","article-title":"Complement components, but not the complement regulators C1 inhibitor and CD59, are upregulated in atherosclerotic plaques","volume":"21","author":"Yasojima","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib122","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2016.12.017_bib119","first-page":"531","article-title":"Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis","volume":"22","author":"Zimmerman-Nielsen","year":"2005","journal-title":"BMC Gastroenterol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801630330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801630330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:22:33Z","timestamp":1692624153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745801630330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":116,"alternative-id":["S019745801630330X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.12.017","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of human diseases caused or exacerbated by aberrant complement activation","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}